Once-daily Simultaneous Modulated Accelerated Radiotherapy
Showing 1 - 25 of >10,000
Small Cell Lung Cancer Trial in Guangzhou (q.d. RT, b.i.d.RT, etoposide and cisplatin)
Unknown status
- Small Cell Lung Cancer
- q.d. RT
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Jan 25, 2021
Esophageal Cancer Trial in Shantou (Radiotherapy with simultaneous modulated accelerated boost, Standard dose radiotherapy, PF)
Recruiting
- Esophageal Cancer
- Radiotherapy with simultaneous modulated accelerated boost
- +2 more
-
Shantou, Guangdong, ChinaCancer Hospital, Shantou University Medical College
Dec 27, 2021
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (SMART, DDP, S-1)
Completed
- Esophageal Squamous Cell Carcinoma
- SMART
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Sep 2, 2020
Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Oct 25, 2022
Soft Tissue Sarcoma Trial in Florence (RT)
Recruiting
- Soft Tissue Sarcoma
- RT
-
Florence, Fi, ItalyAOU Careggi
Feb 27, 2023
Esophageal Tumors Trial in Shantou (SMART, PF)
Completed
- Esophageal Neoplasms
- SMART
- PF
-
Shantou, Guangdong, ChinaCancer Hospital, Shantou University Medical College
Dec 27, 2021
Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- paclitaxel combined with platinum
-
Liuzhou, Guangxi, Chinathe Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)
Active, not recruiting
- Breast Cancer
- DCIS
- APBI: 30 Gy
- APBI: 27.5 Gy
-
Barrie, Ontario, Canada
- +9 more
Apr 4, 2022
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)
Recruiting
- Breast Cancer
- IMRT/VMAT-Based Accelerated Partial Breast Irradiation
-
Worthington, Minnesota
- +2 more
Nov 11, 2022
Bladder Cancer Trial in Seoul (hypo-IMRT)
Recruiting
- Bladder Cancer
- hypo-IMRT
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 6, 2022
Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)
Active, not recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- IMRT
- Nivolumab
-
Atlanta, Georgia
- +3 more
Jan 10, 2023
Breast Cancer Trial in Brussels, Dendermonde (Tomotherapy)
Completed
- Breast Cancer
- Tomotherapy
-
Brussels, Belgium
- +2 more
Jul 19, 2022
Lymphedema Trial in New York (Intensity-modulated radiation therapy (IMRT))
Active, not recruiting
- Lymphedema
- Intensity-modulated radiation therapy (IMRT)
-
New York, New YorkLaura and Issac Perlmutter Cancer Center
Jul 7, 2022
Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)
Completed
- Breast Cancer
- Radiation Toxicity
- Radiotherapy
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Jan 3, 2023
Prostate Cancer Trial in Brussels (MR-guided RT)
Recruiting
- Prostate Cancer
- MR-guided RT
-
Brussels, BelgiumDepartment of Radiotherapy, UZ Brussel, Vrije Universiteit Bruss
May 18, 2022
Non Small Cell Lung Cancer, Brain Metastases Trial in Nanchang (molecular targeted therapies, Brain Radiotherapy)
Unknown status
- Non Small Cell Lung Cancer
- Brain Metastases
- molecular targeted therapies
- Brain Radiotherapy
-
Nanchang, Jiangxi, ChinaThe Second Afiliated Hospital of Nanchang University
Dec 9, 2019
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (radiation, drug, other, procedure)
Recruiting
- Esophagus Cancer
- +2 more
- Intensity Modulated Radiation Therapy
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 6, 2022
Brain Metastases Trial in Vancouver (whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric
Active, not recruiting
- Brain Metastases
- whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Sep 17, 2021
Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)
Recruiting
- Oropharynx Cancer
- therapeutic conventional surgery
- +5 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 4, 2022
Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)
Not yet recruiting
- Hypopharyngeal Cancer
- Cisplatin/Nedaplatin, albumin paclitaxel
- (no location specified)
May 5, 2023
Liver Cancer, Liver Transplant; Complications, Hepatocellular Carcinoma Trial in Shanghai (radiation, combination product, drug)
Not yet recruiting
- Liver Cancer
- +4 more
- intensity-modulated radiotherapy
- +5 more
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Apr 20, 2022
Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant
Completed
- The Primary Study Metric is Progression-free Survival (PFS)
- (no location specified)
Jun 28, 2023
Locally Advanced Cervical Carcinoma Trial (Hypofractionation)
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- Hypofractionation
- (no location specified)
Jun 25, 2022